BDBM549035 2-(((2S,4s,6S)-6-((5-(4-(trifluoromethoxy)phenyl)-1,3,4-oxadiazol-2-yl)amino)spiro[3.3]heptan-2-yl)oxy)nicotinamide::US11299488, Example 16

SMILES NC(=O)c1cccnc1OC1CC2(CC(C2)Nc2nnc(o2)-c2ccc(OC(F)(F)F)cc2)C1

InChI Key InChIKey=ULEGDEBNDNIPBH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 549035   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM549035(2-(((2S,4s,6S)-6-((5-(4-(trifluoromethoxy)phenyl)-...)
Affinity DataIC50: 96nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
US Patent